RetinAI Medical AG and Retina Consultants of America (RCA) have created a strategic alliance to develop an extensive and AI-driven real-world evidence (RWE) database in ophthalmology. This collaboration will use RetinAI’s digital health technologies in conjunction with RCA’s clinic network to analyze real-world clinical and imaging data. The resulting database is intended to give useful information about health outcomes, medication adherence, and treatment regimens. The database will provide complete clinical and imaging data with insightful insights by utilizing RCA’s quality-driven datasets and RetinAI’s Discovery platform. The collaboration is expected to have a substantial impact on data-driven healthcare decisions. The RWE database will allow healthcare stakeholders to acquire insights into drug efficacy, improve drug development processes, and improve patient care.

To know more: About the original article click here.